braftovi
pierre fabre medicament - encorafenib - melanoma; colorectal neoplasms - antineoplastiske midler - encorafenib is indicated:in combination with binimetinib is indicated for the treatment of adult patients with unresectable or metastatic melanoma with a braf v600 mutationin combination with cetuximab, for the treatment of adult patients with metastatic colorectal cancer (crc) with a braf v600e mutation, who have received prior systemic therapy.
mektovi 15 mg
2care4 aps - binimetinib - tablett, filmdrasjert - 15 mg
erwinase 10000 e
porton biopharma limited - krisantaspase - pulver til injeksjons-/infusjonsvæske, oppløsning - 10000 e
cabometyx
ipsen pharma - cabozantinib (s)-malate - carcinoma, renal cell; carcinomas, hepatocellular - antineoplastiske midler - renal cell carcinoma (rcc)cabometyx is indicated as monotherapy for the treatment of advanced renal cell carcinoma (rcc):in treatment-naïve adults with intermediate or poor risk,in adults following prior vascular endothelial growth factor (vegf)-targeted therapy. cabometyx, in combination with nivolumab, is indicated for the first-line treatment of advanced renal cell carcinoma in adults. hepatocellular carcinoma (hcc)cabometyx is indicated as monotherapy for the treatment of hepatocellular carcinoma (hcc) in adults who have previously been treated with sorafenib.
signifor
recordati rare diseases - pasireotide - acromegaly; pituitary acth hypersecretion - hypofysiske og hypotalamiske hormoner og analoger - signifor er indisert for behandling av voksne pasienter med cushings sykdom for hvem kirurgi ikke er et alternativ eller for hvem kirurgi har feilet. signifor er indisert for behandling av voksne pasienter med akromegali der kirurgi er ikke et alternativ, eller har ikke vært kurative og som ikke er tilstrekkelig kontrollert på behandling med en annen somatostatin analog.
metadon dne 5 mg/ ml
dne pharma - metadonhydroklorid - mikstur, oppløsning - 5 mg/ ml
metadon dne 1 mg/ ml
dne pharma - metadonhydroklorid - mikstur, oppløsning - 1 mg/ ml
metadon dne 2 mg/ ml
dne pharma - metadonhydroklorid - mikstur, oppløsning - 2 mg/ ml
bosulif 400 mg
abacus medicine a/s - bosutinibmonohydrat - tablett, filmdrasjert - 400 mg
bosulif 100 mg
2care4 aps - bosutinibmonohydrat - tablett, filmdrasjert - 100 mg